Viewing Study NCT00602433


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-02-27 @ 11:19 AM
Study NCT ID: NCT00602433
Status: COMPLETED
Last Update Posted: 2011-04-15
First Post: 2008-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib
Sponsor: Northwestern University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module